Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2 ; volume:13 ; number:1 ; day:26 ; month:6 ; year:2014 ; pages:1-13 ; date:12.2014
Molecular cancer ; 13, Heft 1 (26.6.2014), 1-13, 12.2014
- Creator
-
Doloff, Joshua C.
Chen, Chong-Sheng
Waxman, David J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-13-158
- URN
-
urn:nbn:de:101:1-2021081501382857288022
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Doloff, Joshua C.
- Chen, Chong-Sheng
- Waxman, David J.
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L
The role of hypoxic signaling in evasive tumor resistance against anti-angiogenic therapy
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L
The role of hypoxic signaling in evasive tumor resistance against anti-angiogenic therapy
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L
The role of hypoxic signaling in evasive tumor resistance against anti-angiogenic therapy
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial